MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutatedMichal Šmída(Central European Institute of Technology), Sebastian Nijman(Austrian Academy of Sciences)Nature CommunicationsDecember 6, 201610.1038/ncomms13701Cited by 45SaveCiteExport RISWatch citationsRelated PapersCD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells|PLoS ONE|2020|25